Churg-strauss syndrome cardiac involvement evaluated by cardiac magnetic resonance imaging and positron-emission tomography: A prospective study on 20 patients

Rheumatology (United Kingdom)

Volumn 52, Issue 4, 2013, Pages 642-650

  Marmursztejn, Julien ^a   Guillevin, Loic ^a   Trebossen, Regine ^a   Cohen, Pascal ^a   Guilpain, Philippe ^a   Pagnoux, Christian ^a   Mouthon, Luc ^a   Legmann, Paul ^a   Vignaux, Olivier ^a   Duboc, Denis ^a  

^a Institut Cochin   (France)

Author keywords

Cardiac magnetic resonance imaging; Inflammation; Vasculitis

Indexed keywords

FLUORODEOXYGLUCOSE; GADOTERIC ACID;

ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CHURG STRAUSS SYNDROME; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING EQUIPMENT; DISEASE DURATION; FEMALE; HEART MUSCLE FIBROSIS; HUMAN; IMAGE ANALYSIS; MALE; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION;

ADULT; CHURG-STRAUSS SYNDROME; DIAGNOSIS, DIFFERENTIAL; FEMALE; FIBROSIS; FLUORODEOXYGLUCOSE F18; HEART DISEASES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDITIS; MYOCARDIUM; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; REMISSION INDUCTION;

EID: 84875624217     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes155     Document Type: Article

References (30)

1. Churg J, Strauss L. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol 1951;27: 277-301.
2. McGavin CR, Marshall AJ, Lewis CT. Churg-Strauss syndrome with critical endomyocardial fibrosis: 10 yearsurvival after combined surgical and medical management. Heart 2002;87:E5.
3. Smedema JP, van Paassen P, van Kroonenburgh MJ et al. Cardiac involvement of Churg Strauss syndrome demonstrated by magnetic resonance imaging. Clin Exp Rheumatol 2004;22:75-8.
4. Stollberger C, Finsterer J, Winkler WB. Eosinophilic pericardial effusion in Churg-Strauss syndrome. Respir Med 2005;99:377-9.
5. Uren NG, Hammond PJ. Myopericarditis in Churg-Strauss syndrome. Tex Heart Inst J 1991;18:127-31.
6. Val-Bernal JF, Mayorga M, Garcia-Alberdi E, Pozueta JA. Churg-Strauss syndrome and sudden cardiac death. Cardiovasc Pathol 2003;12:94-7.
7. Guillevin L, Pagnoux C, Seror R et al. The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the FVSG cohort. Medicine (Baltimore) 2011;90:19-27.
8. Guillevin L. Clinical trials on systemic necrotizing vasculitides. Presse Med 2010;39:653-9.
9. Guillevin L, Cohen P, Gayraud M et al. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore) 1999;78:26-37.
10. Sablé -Fourtassou R, Cohen P, Mahr A et al. Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med 2005;143:632-8.
11. Sinico RA, Di Toma L, Maggiore U et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum 2005;52: 2926-35.
12. Abdel-Aty H, Boye P, Zagrosek A et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol 2005;45:1815-22.
13. Smedema J, Snoep G, van Kroonenburgh M et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 2005;45:1683-90.
14. Vignaux O, Dhote R, Duboc D et al. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study. Chest 2002; 122:1895-901.
15. Mahrholdt H, Goedecke C, Wagner A et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004;109:1250-8.
16. Aso H, Takeda K, Ito T et al. Assessment of myocardial fibrosis in cardiomyopathic hamsters with gadolinium_DTPA-enhanced magnetic resonance imaging. Invest Radiol 1998;33:22-32.
17. Kobayashi Y, Ishii K, Oda K et al. Aortic wall inflammation due to Takayasu arteritis imaged with 18F-FDG PET coregistered with enhanced CT. J Nucl Med 2005;46: 917-22.
18. Andrews J, Al-Nahhas A, Pennell D et al. Non-invasive imaging in the diagnosis and management of Takayasu's arteritis. BMJ 2004;63:995-1000.
19. Moosig F, Czech N, Mehl C et al. Correlation between 18-fluorodeoxyglucose accumulation in large vessels and serological markers of inflammation in polymyalgia rheumatica: a quantitative PET study. BMJ 2004;63: 870-3.
20. Meller J, Strutz F, Siefker U et al. Early diagnosis and follow-up of aortitis with [(18)F] FDG PET and MRI. Eur J Nucl Med Mol Imaging 2003;30:730-6.
21. Rudd J, Warburton E, Fryer T et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 2002;105: 2708-11.
22. Okumura W, Iwasaki T, Toyama T et al. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med 2004;45:1989-98.
23. Masi AT, Hunder GG, Lie JT et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990;33:1094-100.
24. Luqmani RA, Bacon PA, Moots RJ et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 1994;87:671-8.
25. Cerqueira M, Weissman N, Dilsizian V et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105:539-42.
26. Marmursztejn J, Vignaux O, Cohen P et al. Impact of cardiac magnetic resonance imaging for assessment of Churg-Strauss syndrome: a cross-sectional study in 20 patients. Clin Exp Rheumatol 2009;27:70-6.
27. Marmursztejn J, Cohen P, Duboc D et al. Cardiac magnetic resonance imaging in Churg-Strauss-syndrome. Impact of immunosuppressants on outcome assessed in a prospective study on 8 patients. Clin Exp Rheumatol 2010; 28:8-13.
28. Ollinger J. Maximum-likelihood reconstruction of transmission images in emission computed tomography via the EM algorithm. Trans Med Imaging 1994;13:89-101.
29. Morita H, Yokoyama I, Yamada N, Uno K, Nagai R. Usefulness of 18FDG/13N-ammonia PET imaging for evaluation of the cardiac damage in Churg-Strauss syndrome. Eur J Nucl Med Mol Imaging 2004;31:1218.
30. Vignaux O, Marmursztejn J, Cohen P et al. Cardiac imaging in ANCA-associated vasculitis. Presse Med 2007; 36:902-6